Kandori fleck retina is a rare eye disorder that affects the retina, the light-sensitive layer of tissue at the back of the eye. It is characterized by the presence of yellow-white flecks in the retina, which can cause vision loss. It is caused by a mutation in the PROM1 gene, which is responsible for the production of a protein that helps maintain the structure of the retina.

The symptoms of Kandori fleck retina include: decreased vision, central or paracentral scotomas, metamorphopsia, and photopsia. Other symptoms may include reduced color vision, reduced contrast sensitivity, and difficulty reading. In some cases, patients may experience a central or paracentral blind spot.

Kandori fleck retina is a rare eye condition that is caused by a genetic mutation in the ABCA4 gene. This gene is responsible for producing a protein that helps transport vitamin A from the liver to the retina. When this gene is mutated, it can cause a buildup of vitamin A in the retina, leading to the formation of yellowish spots known as Kandori flecks.

The treatment for Kandori fleck retina depends on the severity of the condition. In mild cases, no treatment may be necessary. However, in more severe cases, laser photocoagulation or cryotherapy may be used to reduce the risk of further damage to the retina. In some cases, surgery may be necessary to repair the retina. In addition, regular eye exams and monitoring of the condition are recommended to ensure that any changes in the retina are detected and treated promptly.

1. Family history of retinal disease
2. Diabetes
3. High blood pressure
4. Smoking
5. High cholesterol
6. Age (over 50)
7. Prolonged exposure to sunlight
8. Certain medications, such as corticosteroids and antimalarial drugs
9. Previous eye injury or surgery
10. Certain genetic disorders, such as Stickler syndrome

At this time, there is no known cure for Kandori fleck retina. However, there are medications that can be used to help manage the condition. These medications include corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), and immunosuppressants. Additionally, laser photocoagulation and vitrectomy may be used to help reduce the risk of vision loss.